Q32 Bio has hired José Trevejo as its chief medical officer. The company announced the appointment in a personnel update featured by STAT+.
Trevejo joins from Enveda Therapeutics. There, he served as chief medical officer and head of clinical pipeline strategy. His move marks a change in leadership for Q32 Bio, a company focused on therapeutic development.
The announcement is part of a recurring feature that tracks executive hires and promotions across the biotech and pharmaceutical sectors. By highlighting these transitions, the report provides visibility into shifting leadership roles within the industry.